Patent · US Active

2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection

US10093671B2 · kind B2 · utility

12Cited by

1References

17Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Xingchun Han · Shanghai, CN
Min Jiang · Lexington, US
Song Yang · Shanghai, CN

Key dates

Filing date	Aug 11, 2017
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Aug 11, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and Ar are as described herein, compositions including the compounds and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.